FlowJo is Other Healthcare Technology Systems in United States that focus on kinetic studies business. Founded in 1997. They cover business area such as developer, discovery, human and animal health, single-cell flow, mass cytometry analysis, open-ended plugin architecture, cell cycle, proliferation and kinetic study, research laboratory, institution, critical disease, cancer, HIV, infectious disease.
Other Healthcare Technology Systems
1997
( 27 years old in 2024 )
Kinetic Studies
-
385 Williamson Way
Ashland, OR 97520
United States
Private
developerdiscoveryhuman and animal healthsingle-cell flowmass cytometry analysisopen-ended plugin architecturecell cycleproliferation and kinetic studyresearch laboratoryinstitutioncritical diseasecancerHIVinfectious disease
* We use standard office opening hours in near FlowJo's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
FlowJo is Other Healthcare Technology Systems business from United States that founded in 1997 (27 years old in 2024), FlowJo business is focusing on Kinetic Studies.
FlowJo headquarter office and corporate office address is located in 385 Williamson Way Ashland, OR 97520 United States.
FlowJo was founded in United States.
In 2024, FlowJo is currently focus on kinetic studies sector.
Above is snippet of Google Trends for "kinetic studies" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with FlowJo, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
